1. Home
  2. GETY vs BCYC Comparison

GETY vs BCYC Comparison

Compare GETY & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Getty Images Holdings Inc.

GETY

Getty Images Holdings Inc.

HOLD

Current Price

$0.93

Market Cap

490.7M

Sector

Industrials

ML Signal

HOLD

Logo Bicycle Therapeutics plc

BCYC

Bicycle Therapeutics plc

HOLD

Current Price

$5.28

Market Cap

360.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GETY
BCYC
Founded
1995
2009
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
490.7M
360.7M
IPO Year
2022
2019

Fundamental Metrics

Financial Performance
Metric
GETY
BCYC
Price
$0.93
$5.28
Analyst Decision
Hold
Buy
Analyst Count
3
10
Target Price
$3.78
$13.90
AVG Volume (30 Days)
1.5M
593.0K
Earning Date
05-11-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$926,244,000.00
N/A
Revenue This Year
$0.37
N/A
Revenue Next Year
$1.49
N/A
P/E Ratio
N/A
N/A
Revenue Growth
0.82
N/A
52 Week Low
$0.67
$4.24
52 Week High
$3.21
$9.55

Technical Indicators

Market Signals
Indicator
GETY
BCYC
Relative Strength Index (RSI) 61.14 57.90
Support Level $0.71 $5.03
Resistance Level $0.93 $5.90
Average True Range (ATR) 0.05 0.25
MACD 0.02 0.09
Stochastic Oscillator 87.49 90.99

Price Performance

Historical Comparison
GETY
BCYC

About GETY Getty Images Holdings Inc.

Getty Images Holdings Inc. is a visual content creator and marketplace that offers a full range of content solutions. Through its Getty Images, Stock, and Unsplash brands, websites, and APIs, it serves customers around the world by allowing them to discover, purchase, and share visual content from photographers, illustrators, image partners, and videographers. The company generates a majority of its revenue through subscriptions, offering various subscription products on the Getty Images, iStock, and Unsplash websites. It operates and manages one operating segment, which is the business of developing and commercializing visual content. Geographically, the company generates maximum revenue from the Americas, followed by Europe, the Middle East and Africa, and the Asia-Pacific region.

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

Share on Social Networks: